The ₹1,514-crore initial public offering (IPO) of Glenmark Life Sciences was subscribed 44.17 times on the third and final day. The IPO received bids for 66.33 crore equity shares against the IPO size of over 1.5 crore equity shares, NSE data showed. The qualified institutional buyers portion was subscribed 36.97 times, while that of non-institutional investors was subscribed 122.54 times.